Kailera Therapeutics, Inc. (KLRA) stock
KLRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026
$12.20−0.37 (-2.94%)
Close on Nov 17, 2026Market cap $1.58BP/E –Yield –
Kailera Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Kailera Therapeutics's price to book ratio was 1.7× on Nov 11, 2026.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.7× | – |
See a number that looks wrong?